These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 36753615)

  • 41. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
    Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
    Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthetic nanoparticles for the delivery of CRISPR/Cas9 gene editing system: classification and biomedical applications.
    Zheng Q; Wang W; Zhou Y; Mo J; Chang X; Zha Z; Zha L
    Biomater Sci; 2023 Aug; 11(16):5361-5389. PubMed ID: 37381725
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Application of CRISPR/Cas9 technology in sepsis research.
    Wu M; Hu N; Du X; Wei J
    Brief Funct Genomics; 2020 May; 19(3):229-234. PubMed ID: 32058568
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A glance at genome editing with CRISPR-Cas9 technology.
    Barman A; Deb B; Chakraborty S
    Curr Genet; 2020 Jun; 66(3):447-462. PubMed ID: 31691023
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CRISPR-Cas9 system: A new-fangled dawn in gene editing.
    Gupta D; Bhattacharjee O; Mandal D; Sen MK; Dey D; Dasgupta A; Kazi TA; Gupta R; Sinharoy S; Acharya K; Chattopadhyay D; Ravichandiran V; Roy S; Ghosh D
    Life Sci; 2019 Sep; 232():116636. PubMed ID: 31295471
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapeutic applications of CRISPR/Cas9 gene editing technology for the treatment of ocular diseases.
    Sundaresan Y; Yacoub S; Kodati B; Amankwa CE; Raola A; Zode G
    FEBS J; 2023 Nov; 290(22):5248-5269. PubMed ID: 36877952
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CRISPR-Cas9 Technology for the Creation of Biological Avatars Capable of Modeling and Treating Pathologies: From Discovery to the Latest Improvements.
    Nasrallah A; Sulpice E; Kobaisi F; Gidrol X; Rachidi W
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429042
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CRISPR/Cas9: an advanced tool for editing plant genomes.
    Samanta MK; Dey A; Gayen S
    Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Precision genome editing in plants: state-of-the-art in CRISPR/Cas9-based genome engineering.
    Wada N; Ueta R; Osakabe Y; Osakabe K
    BMC Plant Biol; 2020 May; 20(1):234. PubMed ID: 32450802
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
    Doetschman T; Georgieva T
    Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recent Progress in CRISPR/Cas9 Technology.
    Mei Y; Wang Y; Chen H; Sun ZS; Ju XD
    J Genet Genomics; 2016 Feb; 43(2):63-75. PubMed ID: 26924689
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CRISPR/Cas based gene editing: marking a new era in medical science.
    Prasad K; George A; Ravi NS; Mohankumar KM
    Mol Biol Rep; 2021 May; 48(5):4879-4895. PubMed ID: 34143395
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CRISPR-Cas9 therapies in experimental mouse models of cancer.
    Estêvão D; Rios Costa N; da Costa RG; Medeiros R
    Future Oncol; 2018 Aug; 14(20):2083-2095. PubMed ID: 30027767
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recent Advances in CRISPR/Cas9 Delivery Approaches for Therapeutic Gene Editing of Stem Cells.
    Lotfi M; Morshedi Rad D; Mashhadi SS; Ashouri A; Mojarrad M; Mozaffari-Jovin S; Farrokhi S; Hashemi M; Lotfi M; Ebrahimi Warkiani M; Abbaszadegan MR
    Stem Cell Rev Rep; 2023 Nov; 19(8):2576-2596. PubMed ID: 37723364
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CRISPR/Cas9-mediated noncoding RNA editing in human cancers.
    Yang J; Meng X; Pan J; Jiang N; Zhou C; Wu Z; Gong Z
    RNA Biol; 2018 Jan; 15(1):35-43. PubMed ID: 29028415
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing.
    Sinclair F; Begum AA; Dai CC; Toth I; Moyle PM
    Drug Deliv Transl Res; 2023 May; 13(5):1500-1519. PubMed ID: 36988873
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic applications of CRISPR/Cas9 system in gene therapy.
    Mollanoori H; Teimourian S
    Biotechnol Lett; 2018 Jun; 40(6):907-914. PubMed ID: 29704220
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CRISPR/Cas9 Genome Editing: A Promising Tool for Therapeutic Applications of Induced Pluripotent Stem Cells.
    Zhang Y; Sastre D; Wang F
    Curr Stem Cell Res Ther; 2018; 13(4):243-251. PubMed ID: 29446747
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Applications of CRISPR-Cas9 Technology to Genome Editing in Glioblastoma Multiforme.
    Al-Sammarraie N; Ray SK
    Cells; 2021 Sep; 10(9):. PubMed ID: 34571991
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The CRISPR/Cas9 system and its applications in crop genome editing.
    Bao A; Burritt DJ; Chen H; Zhou X; Cao D; Tran LP
    Crit Rev Biotechnol; 2019 May; 39(3):321-336. PubMed ID: 30646772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.